SCHEMBL32678152

SCHEMBL32678152

Nc1nc2ccc(C(=O)N3CCCC3)cc2s1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.67
▸ CYP3A4 P08684 1/20 0.67
▸ CYP2D6 P10635 1/20 0.67
▸ CYP2C9 P11712 1/20 0.67
▸ HPGD P15428 2/20 0.62
▸ TSHR P16473 1/20 0.62
▸ HTT P42858 1/20 0.62
▸ GPR183 P32249 10/20 0.62
▸ KCNH2 Q12809 1/20 0.62
▸ MAPK1 P28482 2/20 0.59
▸ LMNA P02545 2/20 0.59
▸ CRBN Q96SW2 1/20 0.58
▸ ACP1 P24666 1/20 0.58
▸ DRD2 P14416 1/20 0.57
▸ NPC1 O15118 1/20 0.57
▸ RAB9A P51151 1/20 0.57
▸ HSD11B1 P28845 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL557523 1.00 CYP1A2 (0.67) CYP1A2CYP3A4CYP2D6CYP2C9HPGD
SCHEMBL32678110 0.99 CYP1A2 (0.66) CYP1A2CYP3A4CYP2D6CYP2C9HPGD
SCHEMBL32678113 0.99 CYP1A2 (0.66) CYP1A2CYP3A4CYP2D6CYP2C9HPGD
SCHEMBL3089549 0.88 HPGD (0.65) CYP1A2CYP3A4CYP2D6CYP2C9HPGD
SCHEMBL22242743 0.87 CYP1A2 (0.72) CYP1A2CYP3A4CYP2D6CYP2C9HPGD
SCHEMBL32678212 0.84 CRBN (0.60) CYP1A2CYP3A4CYP2D6CYP2C9HPGD
SCHEMBL32678209 0.84 CRBN (0.60) CYP1A2CYP3A4CYP2D6CYP2C9HPGD
SCHEMBL14970147 0.83 HPGD (0.81) CYP1A2CYP3A4CYP2D6CYP2C9HPGD
SCHEMBL20467422 0.82 HPGD (0.71) HPGD
SCHEMBL12963767 0.82 HPGD (0.79) HPGDTSHRHTTMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026043617-A1 COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF HEALTH CONDITIONS AND DRUG SCREENING REGLAGENE, INC. (US) 2026-02-26 — — WO disclosed
Send feedback